Evidence map›Paper›PMID 20505147›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2010

Nicotine inhibits Fc epsilon RI-induced cysteinyl leukotrienes and cytokine production without affecting mast cell degranulation through alpha 7/alpha 9/alpha 10-nicotinic receptors.

Neerad C Mishra, Jules Rir-sima-ah, R Thomas Boyd, Shashi P Singh, Sravanthi Gundavarapu, Raymond J Langley, Seddigheh Razani-Boroujerdi, Mohan L Sopori

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Dual Effects of Acetylcholine on Mast Cell-Nerve Interactions.Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. The controversial effect of smoking and nicotine in SARS-CoV-2 infection.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2023
    Review
  9. Review
  10. Review
  11. Neuroimmune Interactions in Peripheral Organs.Annual review of neuroscience · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Amyloid Beta Peptide (AβJournal of clinical medicine · 2020
    Article
  18. Article
  19. Thirdhand smoke component can exacerbate a mouse asthma model through mast cells.The Journal of allergy and clinical immunology · 2018
    Article
  20. Stimulation of nAchRα7 Receptor Inhibits TNF Synthesis and Secretion in Response to LPS Treatment of Mast Cells by Targeting ERK1/2 and TACE Activation.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Neerad C MishraImmunology and Asthma Division, Lovelace Respiratory Research Institute, Albuquerque, NM 87108, USA.
Jules Rir-sima-ah
R Thomas Boyd
Shashi P Singh
Sravanthi Gundavarapu
Raymond J Langley
Seddigheh Razani-Boroujerdi
Mohan L Sopori
Lovelace Respiratory Research Institute · USThe Ohio State University · US

Funding

Nicotine &Immunopathogenesis of Cryptococcal meningitisR01DA017003 · NIDA · LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE · PI SOPORI, MOHAN L. · 2003 to 2007
$2.0M
T Cell Nicotinic ReceptorsR01DA004208 · NIDA · LOVELACE RESPIRATORY RESEARCH INSTITUTE · PI SOPORI, MOHAN L. · 1986 to 2003
$1.9M
NIDA NIH HHS R01 DA004208NIDA NIH HHS R01 DA017003NIDA NIH HHS R01 DA04208-17NIDA NIH HHS R01 DA04208S
6 · The paper itself

Abstract

Smokers are less likely to develop some inflammatory and allergic diseases. In Brown-Norway rats, nicotine inhibits several parameters of allergic asthma, including the production of Th2 cytokines and the cysteinyl leukotriene LTC(4). Cysteinyl leukotrienes are primarily produced by mast cells, and these cells play a central role in allergic asthma. Mast cells express a high-affinity receptor for IgE (FcepsilonRI). Following its cross-linking, cells degranulate and release preformed inflammatory mediators (early phase) and synthesize and secrete cytokines/chemokines and leukotrienes (late phase). The mechanism by which nicotine modulates mast cell activation is unclear. Using alpha-bungarotoxin binding and quantitative PCR and PCR product sequencing, we showed that the rat mast/basophil cell line RBL-2H3 expresses nicotinic acetylcholine receptors (nAChRs) alpha7, alpha9, and alpha10; exposure to exceedingly low concentrations of nicotine (nanomolar), but not the biologically inactive metabolite cotinine, for > or = 8 h suppressed the late phase (leukotriene/cytokine production) but not degranulation (histamine and hexosaminidase release). These effects were unrelated to those of nicotine on intracellular free calcium concentration but were causally associated with the inhibition of cytosolic phospholipase A(2) activity and the PI3K/ERK/NF-kappaB pathway, including phosphorylation of Akt and ERK and nuclear translocation of NF-kappaB. The suppressive effect of nicotine on the late-phase response was blocked by the alpha7/alpha9-nAChR antagonists methyllycaconitine and alpha-bungarotoxin, as well as by small interfering RNA knockdown of alpha7-, alpha9-, or alpha10-nAChRs, suggesting a functional interaction between alpha7-, alpha9-, and alpha10-nAChRs that might explain the response of RBL cells to nanomolar concentrations of nicotine. This "hybrid" receptor might serve as a target for novel antiallergic/antiasthmatic therapies.

Indexed as

alpha7 Nicotinic Acetylcholine ReceptorAnimalsBasophilsCell DegranulationCell Line, TumorCysteineCytokinesCytosolDown-RegulationLeukotrienesMAP Kinase Signaling SystemMast CellsNicotinePhospholipase A2 InhibitorsPhospholipases A2Ratsalpha7 Nicotinic Acetylcholine ReceptorChrna10 protein, ratChrna7 protein, ratChrna9 protein, ratCysteinecysteinyl-leukotrieneCytokinesLeukotrienesNicotinePhospholipase A2 InhibitorsPhospholipases A2Receptors, IgEReceptors, NicotinicTobacco Smoke Pollution

Identifiers

PMID20505147
PMCPMC2954495
OpenAlexW1925634785

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.